Bank Of Stockton Eli Lilly & CO Transaction History

Bank Of Stockton

$331 Million
Q3 2024

A detailed history of Bank Of Stockton transactions in Eli Lilly & CO stock. As of the latest transaction made, Bank Of Stockton holds 493 shares of LLY stock, worth $392,265. This represents 0.13% of its overall portfolio holdings.

Number of Shares

493

Previous 503 1.99%

Holding current value

$392,265

Previous $455,000 4.18%

% of portfolio

0.13%

Previous 0.14%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$772.14 - $960.02 $7,721 - $9,600	-10 Reduced 1.99%	493 $436,000
Q2 2024 Jul 24, 2024	SELL	$724.87 - $909.04 $34,068 - $42,724	-47 Reduced 8.55%	503 $455,000
Q2 2023 Jul 31, 2023	BUY	$350.74 - $468.98 $192,907 - $257,939	550 New	550 $257,000
Q4 2022 Jan 17, 2023	BUY	$321.55 - $374.67 $236,339 - $275,382	735 New	735 $269,000
Q2 2022 Jul 22, 2022	SELL	$278.73 - $327.27 $195,111 - $229,089	-700 Closed	0 $0
Q1 2022 Apr 27, 2022	BUY	$234.69 - $291.66 $164,283 - $204,162	700 New	700 $200,000
Q4 2020 Jan 28, 2021	SELL	$130.46 - $172.63 $264,181 - $349,575	-2,025 Closed	0 $0
Q3 2020 Nov 23, 2020	SELL	$146.22 - $169.13 $259,540 - $300,205	-1,775 Reduced 46.71%	2,025 $299,000
Q2 2020 Jul 23, 2020	BUY	$136.42 - $164.18 $518,395 - $623,884	3,800 New	3,800 $623,000
Q1 2019 Apr 17, 2019	SELL	$111.31 - $131.02 $378,454 - $445,468	-3,400 Closed	0 $0
Q2 2018 Jul 13, 2018	SELL	$75.7 - $86.88 $64,723 - $74,282	-855 Reduced 20.09%	3,400 $289,000
Q1 2018 Apr 27, 2018	SELL	$74.21 - $87.6 $63,078 - $74,460	-850 Reduced 16.65%	4,255 $328,000
Q4 2017 Jan 25, 2018	BUY	$81.94 - $87.89 $98,737 - $105,907	1,205 Added 30.9%	5,105 $430,000
Q3 2017 Nov 06, 2017	BUY	$77.07 - $85.54 $300,573 - $333,606	3,900	3,900 $333,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Stockton, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Stockton with notifications on news.

Account